Gordon Binder

Last updated
Gordon M. Binder
Born1935
NationalityAmerican
Education Purdue University (B.S.E.E)
Harvard Business School (M.B.A)
Occupations
  • Businessman
  • investor
  • scientist

Gordon M. Binder (born 1935) is an American businessman. [1] [2] [3]

Contents

Early life and education

Gordon Binder was born in Missouri. [2] He graduated from Purdue University with a Bachelor of Science in Electrical Engineering and received an M.B.A. from the Harvard Business School as a Baker Scholar. [1] [2]

Career

Binder worked in managing position at Litton Industries and the Ford Motor Company. [1] [3] He served as Chief Financial Officer at the System Development Corporation. [1] [3] In 1982, he joined Amgen as CFO. [1] From 1988 to 2000, he served as its CEO. [1] [3] [4]

He is the Founder and Managing Director of Coastview Capital, a private investment firm. [1] [3] [5] He also serves as Chairman of SRU Biosystems. [6] He sits on the Boards of Directors of Acadia Pharmaceuticals, Cellular Genomics, PhRMA and the Biotechnology Industry Organization. [1] [3] along with Henri Termeer. [7]

He is a member of the Board of Trustees of the Massachusetts Institute of Technology, the California Institute of Technology and the American Enterprise Institute. [1] [3] [8] [9] He was elected a Fellow of the American Academy of Arts and Sciences in 2001. [10]

Bibliography

Related Research Articles

<span class="mw-page-title-main">Rajat Gupta</span> Indian-American business executive (born 1948)

Rajat Kumar Gupta is an Indian-American business executive and convicted felon who, as CEO, was the first foreign-born managing director of management consultancy firm McKinsey & Company from 1994 to 2003. In 2012, he was convicted for insider trading and spent two years in prison. Gupta was a board member of corporations including Goldman Sachs, Procter & Gamble and American Airlines, as well as an advisor to non-profit organizations such as the Bill & Melinda Gates Foundation and The Global Fund to Fight AIDS, Tuberculosis and Malaria. He is the co-founder of the Indian School of Business, American India Foundation, New Silk Route and Scandent Solutions.

Bruce Stanley Kovner is an American billionaire hedge fund manager and philanthropist. He is chairman of CAM Capital, which he established in January 2012 to manage his investment, trading and business activities. From 1983 through 2011, Kovner was founder and chairman of Caxton Associates, a diversified trading company. As of April 2022, his net worth was estimated at US$6.2 billion.

<span class="mw-page-title-main">Ron Williams</span> American businessperson

Ronald Allen Williams is an American businessman and board director on corporate, public sector and non-profit boards. Williams is the author of Learning to Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization, which appeared on The Wall Street Journal's best seller list. He is founder, chairman and CEO of RW2 Enterprises, LLC. He is the former chairman, president and chief executive officer (CEO) of Aetna Inc., a diversified benefits company. Aetna is now part of CVS Health.

Harvey Golub is an American businessman.

Gordon M. "Gord" Nixon, was the president, CEO and director of Royal Bank of Canada, from 2001 to 2014. He is chairman of Bell Canada Enterprises, lead director of George Weston Limited, director and chairman of the corporate governance committee of BlackRock Inc. and is on the advisory committee of KingSett Capital.

Sheridan Gray Snyder OBE is an entrepreneur, venture capitalist, and philanthropist in the biotechnology industry. He is the founder and CEO of Biocatalyst, Genzyme and others.

<span class="mw-page-title-main">President's Council of Advisors on Science and Technology</span> White House advisory board

The President's Council of Advisors on Science and Technology (PCAST) is a council, chartered in each administration with a broad mandate to advise the president of the United States on science and technology. The current PCAST was established by Executive Order 13226 on September 30, 2001, by George W. Bush, was re-chartered by Barack Obama's April 21, 2010, Executive Order 13539, by Donald Trump's October 22, 2019, Executive Order 13895, and by Joe Biden's February 1, 2021, Executive Order 14007.

<span class="mw-page-title-main">Robert K. Steel</span> American businessman

Robert King Steel is an American businessman, financier and government official who has served as Deputy Mayor for Economic Development in the administration of New York City Mayor Michael Bloomberg, Under Secretary for Domestic Finance of the United States Treasury, chief executive officer of Wachovia Corporation and vice chairman of Goldman Sachs. He has also served as chairman of the board of trustees at Duke University and the Aspen Institute. In May 2014, he was tapped to succeed Joseph R. Perella as chief executive officer of Perella Weinberg Partners, a private investment banking and asset management firm.

Daniel Anthony D'Aniello is an American billionaire businessman. He is the cofounder and chairman of the Carlyle Group, a private equity firm headquartered in Washington, D.C.

<span class="mw-page-title-main">Jim Breyer</span> American venture capitalist (born 1961)

James W. Breyer is an American venture capitalist, founder and chief executive officer of Breyer Capital, an investment and venture philanthropy firm, and a former managing partner at Accel Partners, a venture capital firm. Breyer has invested in over 40 companies that have gone public or completed a merger, with some of these investments, including Facebook, earning over 100 times cost and many others over 25 times cost. On the Forbes 2021 list of the 400 richest Americans, he was ranked #389, with a net worth of US$2.9 billion.

<span class="mw-page-title-main">Wanda Austin</span> American CEO

Wanda M. Austin is a former president and CEO of The Aerospace Corporation. She was both the first woman, and the first African-American, to hold this position. Austin also served as interim president for the University of Southern California, following the resignation of C. L. Max Nikias. She was both the first woman, and the first African-American, to hold this position.

Frederick W. Gluck was a longtime top senior partner and director at management consultancy McKinsey & Company, serving as managing director from 1988 to 1994. At McKinsey he introduced the concept of fifteen “centers of competence”. He is a director at Amgen Inc. and holds directorships in public, private, and non-profit organizations.

Life Sciences Foundation (LSF) was a San Francisco-based nonprofit organization that was established in 2011 to collect, preserve, interpret, and promote the history of biotechnology. LSF conducted historical research, maintained archives and published historically relevant materials and information.

Raymond J. Lane is an American business executive and strategist specializing in technology and finance. Lane is best known for assisting corporations with technology strategy, organizational development, team building, and sales and growth management.

<span class="mw-page-title-main">Robert A. Bradway</span> American businessman

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Marc Stern is an American attorney, business executive and philanthropist. He serves as the Chairman of the TCW Group, an asset management financial institution based in Los Angeles, California. He also owns minority stakes in Major League Baseball's Milwaukee Brewers and the NBA's Milwaukee Bucks. Marc serves as the Chairman of the Los Angeles Opera.

Anthony Aouni Tamer is an American billionaire businessman, and the founder and Co-CEO of H.I.G. Capital, a global private equity and alternative assets investment firm with $48 billion of equity capital under management. He previously held positions at Bain & Company, Hewlett-Packard, and Sprint Corporation. The Forbes magazine lists him as the No. 638 richest person in the world, with a net worth of $4.5 billion as of May 2021.

<span class="mw-page-title-main">Henri Termeer</span>

Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.

Leo Guthart is an American economist and businessman. Guthart is a former Vice Chairman of the Pittway Corporation, and co-founder of the Long Island Research Institute, Topspin Partners, and the Long Island Venture Fund.

References

  1. 1 2 3 4 5 6 7 8 9 "Gordon M. Binder", Bloomberg Business Week, nd, archived from the original on June 5, 2013
  2. 1 2 3 Harvard Business School
  3. 1 2 3 4 5 6 7 "Biography", Milken Institute, nd, archived from the original on 2013-06-19
  4. Lawrence M. Fisher, BUSINESS PEOPLE; Amgen Officer Shifts Surprise to Analysts, The New York Times , October 27, 1988
  5. Bloomerg BusinessWeek: Coastview Capital
  6. A Sharper Nose for Danger, Bloomberg BusinessWeek , May 24, 2004
  7. Terrapinn Holdings Ltd (2015). Mr Henri Termeer: Chief Executive Officer, Former Genzyme. Orphan Drug Congress. Retrieved 27 September 2015.
  8. The MIT Corporation
  9. American Enterprise Institute Board of Trustees
  10. "Book of Members, 1780–2010: Chapter B" (PDF). American Academy of Arts and Sciences. Retrieved July 20, 2011.